ARVN Arvinas, Inc.
Healthcare$9.09-0.11%ClosedMarket Cap: $586.5M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$14.75
Target (Median)
$14.50
Target Range
$10.00 - $20.00
Upside from current price: 62.3%
Rating Distribution
2 Strong Buy8 Buy8 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | BTIG | maintain | Buy | Buy |
| 2026-05-13 | Barclays | maintain | Overweight | Overweight |
| 2026-05-04 | Citigroup | maintain | Buy | Buy |
| 2026-03-19 | Citigroup | maintain | Buy | Buy |
| 2026-03-19 | BTIG | maintain | Buy | Buy |
| 2026-02-25 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-25 | Wedbush | maintain | Neutral | Neutral |
| 2026-02-25 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-01-06 | Citigroup | upgrade | Buy | Neutral |
| 2025-12-17 | Barclays | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.42 | $74.6M | 13 |
| Sun Dec 31 | $-3.07 | $75.7M | 10 |
| Mon Dec 31 | $-2.39 | $104.3M | 4 |
| Tue Dec 31 | $-1.77 | $160.4M | 4 |